Liver function and drug breakdown: a new study on mirdametinib

NCT ID NCT06997276

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how the drug mirdametinib is absorbed and removed from the body in people with moderate or severe liver problems compared to those with normal liver function. It involves 32 adults and is for research only, not to treat any condition. The goal is to understand safety and how the liver affects the drug's levels in the blood.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

liver disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • American Research Corporation (Texas Liver Institute)

    RECRUITING

    San Antonio, Texas, 78215, United States

    Contact Email: •••••@•••••

    Contact

  • Clinical Pharmacology of Miami

    RECRUITING

    Miami, Florida, 33172, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Orlando Clinical Research Center

    RECRUITING

    Orlando, Florida, 32809, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact